An image of Ciara Doran, Director at Sansanima
Video, 17 mins

Commercialisation Conversations - Sansanima

Ethical concerns surrounding animal research have prompted a need for alternative methods to be developed.

Led by researchers at the University of Sheffield, Sansanima has created a technology that replaces animal research in the manufacturing of clostridial neurotoxin-based medical products.

The new technology will prevent animals from being used to quality control major global medicines like the tetanus vaccine.

Credits

Project Leads

See also